Population Pharmacokinetic Modeling of Remifentanil in Infants with Unrepaired Tetralogy of Fallot.

Jing Chang,Yang Shen,Yue Huang,Ying Sun,Mei-Hua Cai,Jing Niu,Li-Ming Zhang,Ji-Jian Zheng,Ma-Zhong Zhang
DOI: https://doi.org/10.1007/s13318-018-0489-3
2018-01-01
European Journal of Drug Metabolism and Pharmacokinetics
Abstract:Although there is literature suggesting that pathophysiologic changes in children with congenital heart disease alter the pharmacokinetics of anesthetics and may result in dosage adjustment, limited information exists regarding the pharmacokinetics of remifentanil in infants with unrepaired tetralogy of Fallot (TOF). The objectives of the current analysis were to characterize the population pharmacokinetics of remifentanil in infants, and to evaluate the effects of TOF on remifentanil’s pharmacokinetics.
What problem does this paper attempt to address?